Dechra Pharmaceuticals (DPH)

Sector: Pharma and Biotech     Index: FTSE 250
-0.06%
-1.00p
1,698.00p
17:30 24/03/17
1,698.00p
17:30 24/03/17
DAILY VARIATION
-0.06%
-1.00p
VOLUME
165,690
REAL TIME BATS
1,696.00p
17:36 24/03/17
0.00%
0.00p
DATA
52 Week High
1,708.00p
52 Week Low
1,021.00p
Shares Issued
93.07m
Market Cap
£1,580.26m
RiskGrade
103
Beta
0.74
MENU

Dechra Pharmaceuticals Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 1.1% 1.2%
Div Cover 2.3 2.9
Op Mrgn 7.9% 20.7%
ROCE 15.1%
Latest F'cast
P/E 39.5 27.3
PEG 5.7 0.6
Pr/Revenue 6.4 4.4
Pr/Book 5.7
Latest F'cast
Revenue 21.7% 31.0%
PBT -43.6% n/a
EPS 6.9% 23.9%
DPS 9.0% 5.5%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2012-06-30 124.33 6.11 21.35p 22.8 -0.6 -39% 12.60p 2.6%
2013-06-30 189.18 12.48 29.27p 23.6 0.6 37% 14.00p 2.0%
2014-06-30 193.57 21.44 36.45p 19.8 0.8 25% 15.40p 2.1%
2015-06-30 203.48 25.81 40.17p 24.5 2.4 10% 16.94p 1.7%
2016-06-30 247.56 14.55 42.95p 27.3 3.9 7% 18.46p 1.6%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-06-30 356.23 73.80 61.47p 27.3 0.6 43% 20.86p 1.2%
2018-06-30 390.61 86.49 71.53p 23.8 1.5 16% 23.25p 1.4%

Regulatory News

slide to see more
Additional Listing 23-Mar-17 07:04
Director/PDMR Shareholding 21-Mar-17 14:10
Director Declaration 17-Mar-17 15:18

Latest Sharecast News

slide to see more

Newspaper Links

No results found